| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients.
|
Br J Cancer
|
1997
|
1.54
|
|
2
|
Formation of chloroethylamine and 1,3-oxazolidine-2-one following ifosfamide administration in humans.
|
Drug Metab Dispos
|
1995
|
1.39
|
|
3
|
Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomas.
|
Ann Oncol
|
1995
|
1.18
|
|
4
|
Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer.
|
Ann Oncol
|
1996
|
1.16
|
|
5
|
Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study.
|
Br J Cancer
|
1995
|
1.16
|
|
6
|
Changing phenotype of gastrointestinal stromal tumours under imatinib mesylate treatment: a potential diagnostic pitfall.
|
Histopathology
|
2005
|
1.07
|
|
7
|
A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors.
|
Clin Cancer Res
|
1998
|
1.05
|
|
8
|
Alkaline phosphatase isoenzyme patterns in malignant disease.
|
Clin Chem
|
1992
|
1.04
|
|
9
|
Evaluation of tumour angiogenesis as a prognostic marker in malignant mesothelioma.
|
J Pathol
|
1997
|
0.98
|
|
10
|
Soft tissue sarcoma in adults.
|
Curr Opin Oncol
|
1999
|
0.98
|
|
11
|
Quality control in multicentric clinical trials. An experience of the EORTC Gynecological Cancer Cooperative Group.
|
Eur J Cancer
|
2000
|
0.93
|
|
12
|
The treatment of advanced ovarian carcinoma (I): clinical variables associated with prognosis.
|
Gynecol Oncol
|
1988
|
0.92
|
|
13
|
Re: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.
|
J Natl Cancer Inst
|
1995
|
0.91
|
|
14
|
Carminomycin vs adriamycin in advanced soft tissue sarcomas: an EORTC randomised phase II study.
|
Eur J Cancer Clin Oncol
|
1983
|
0.91
|
|
15
|
Correlation of intratumoral microvessel density and p53 protein overexpression in human colorectal adenocarcinoma.
|
Microvasc Res
|
1996
|
0.89
|
|
16
|
Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma.
|
Breast Cancer Res Treat
|
1997
|
0.88
|
|
17
|
Ecteinascidin-743: evidence of activity in advanced, pretreated soft tissue and bone sarcoma patients.
|
Sarcoma
|
2006
|
0.86
|
|
18
|
The impact of drug administration sequence and pharmacokinetic interaction in a phase I study of the combination of docetaxel and gemcitabine in patients with advanced solid tumors.
|
Anticancer Drugs
|
2002
|
0.84
|
|
19
|
Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG).
|
Cancer Chemother Pharmacol
|
1983
|
0.84
|
|
20
|
Pulmonary toxicity and bleomycin.
|
Lancet
|
1994
|
0.83
|
|
21
|
Chemotherapy administration and data collection in an EORTC collaborative group--can we trust the results?
|
Eur J Cancer
|
1993
|
0.83
|
|
22
|
In vitro toxicity studies with mitomycins and bleomycin on endothelial cells.
|
Anticancer Drugs
|
1997
|
0.83
|
|
23
|
The role of ifosfamide in the treatment of adult soft tissue sarcomas, Ewing's sarcoma, and osteosarcoma: a review.
|
Semin Oncol
|
1990
|
0.83
|
|
24
|
Cyclophosphamide, adriamycin and cisplatin combination chemotherapy in advanced bladder carcinoma: an EORTC phase II study.
|
Eur J Cancer Clin Oncol
|
1982
|
0.82
|
|
25
|
Correlation of the fractions of proliferating tumor and endothelial cells in breast and colorectal adenocarcinoma is independent of tumor histiotype and microvessel density.
|
Microvasc Res
|
1997
|
0.82
|
|
26
|
Pharmacokinetics and bioavailability of oral 5'-deoxy-5-fluorouridine in cancer patients.
|
Br J Clin Pharmacol
|
1999
|
0.81
|
|
27
|
Soft tissue sarcoma in adults.
|
Curr Opin Oncol
|
1997
|
0.81
|
|
28
|
Serum basic fibroblast growth factor and vascular endothelial growth factor in metastatic renal cell carcinoma treated with interferon alfa-2b.
|
J Natl Cancer Inst
|
1997
|
0.81
|
|
29
|
Chondrosarcoma and other rare bone sarcomas.
|
Curr Opin Oncol
|
1991
|
0.81
|
|
30
|
Real-time quantitative RT-PCR and detection of tumour cell dissemination in breast cancer patients: plasmid versus cell line dilutions.
|
Ann Oncol
|
2003
|
0.81
|
|
31
|
Combination chemotherapy with cis-diammine-dichloro-platinum, vinblastine, and bleomycin in advanced testicular non-seminoma.
|
Lancet
|
1979
|
0.81
|
|
32
|
Pharmacokinetics of ifosfamide are changed by combination with docetaxel: results of a phase I pharmacologic study.
|
Am J Clin Oncol
|
2000
|
0.81
|
|
33
|
The treatment of advanced ovarian carcinoma (II): interval reassessment operations during chemotherapy.
|
Gynecol Oncol
|
1988
|
0.79
|
|
34
|
Pharmacokinetics of intravenous and oral cyclophosphamide in the presence of methotrexate and fluorouracil.
|
Pharm Weekbl Sci
|
1988
|
0.79
|
|
35
|
Predictive testing in cancer chemotherapy. II. In vitro.
|
Pharm Weekbl Sci
|
1985
|
0.79
|
|
36
|
Sternal resection for primary presternal and retrosternal mediastinal liposarcoma.
|
Eur J Cardiothorac Surg
|
1996
|
0.79
|
|
37
|
EORTC New Drug Development Office coordinating and monitoring programme for phase I and II trials with new anticancer agents.
|
Eur J Cancer
|
1991
|
0.78
|
|
38
|
Hodgkin's disease in a patient with Von Hippel-Lindau disease. A case report.
|
Acta Clin Belg
|
2000
|
0.78
|
|
39
|
Role of red blood cells in pharmacokinetics of chemotherapeutic agents.
|
Anticancer Drugs
|
1999
|
0.78
|
|
40
|
Correlation of the response to cisplatin of human ovarian cancer cell lines, originating from one tumor but with different sensitivity, with the recovery of DNA adducts.
|
Biochem Pharmacol
|
1996
|
0.78
|
|
41
|
The human tumour colony-forming assay using fresh specimens.
|
Neth J Med
|
1986
|
0.78
|
|
42
|
In vitro and in vivo chemosensitizing effect of cyclosporin A on an intrinsic multidrug-resistant rat colon tumour.
|
J Cancer Res Clin Oncol
|
1993
|
0.77
|
|
43
|
Resistance patterns between cis-diamminedichloroplatinum(II) and ionizing radiation.
|
Cancer Res
|
1991
|
0.77
|
|
44
|
The role of ifosfamide in the treatment of sarcomas.
|
Semin Oncol
|
1989
|
0.77
|
|
45
|
Partitioning of ifosfamide and its metabolites between red blood cells and plasma.
|
J Pharm Sci
|
1996
|
0.76
|
|
46
|
Activated oxazaphosphorines are transported predominantly by erythrocytes.
|
Ann Oncol
|
1997
|
0.76
|
|
47
|
Multivariate analysis of prognostic variables in patients with disseminated non-seminomatous testicular cancer: results from an EORTC multi-institutional phase III study.
|
Int J Androl
|
1987
|
0.76
|
|
48
|
Diagnosis and treatment of soft tissue sarcomas in adults.
|
Curr Opin Oncol
|
1995
|
0.76
|
|
49
|
Response criteria phase II/phase III invasive bladder cancer.
|
Prog Clin Biol Res
|
1986
|
0.76
|
|
50
|
CA 125 and TPA as markers in ovarian carcinoma.
|
Neth J Med
|
1985
|
0.75
|
|
51
|
Carminomycin versus doxorubicin in advanced breast cancer, a randomized phase II study of the E.O.R.T.C. Breast Cancer Cooperative Group.
|
Eur J Cancer Clin Oncol
|
1986
|
0.75
|
|
52
|
High endothelial cell proliferation index and high microvessel density in vascular hotspots suggest an active angiogenic process in human colorectal adenocarcinomas. Angiogenesis Group.
|
Br J Cancer
|
1996
|
0.75
|
|
53
|
Microvascular count and prognosis in colorectal cancer.
|
J Clin Oncol
|
1996
|
0.75
|
|
54
|
Phase IB study of doxorubicin in combination with the multidrug resistance reversing agent S9788 in advanced colorectal and renal cell cancer.
|
Br J Cancer
|
1997
|
0.75
|
|
55
|
Primary mediastinal leiomyosarcoma.
|
Thorac Cardiovasc Surg
|
1993
|
0.75
|
|
56
|
5-fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer.
|
Cancer
|
1995
|
0.75
|
|
57
|
Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma Group.
|
J Cancer Res Clin Oncol
|
1991
|
0.75
|
|
58
|
Neoadjuvant and adjuvant therapy for invasive bladder tumors.
|
Eur J Cancer
|
1991
|
0.75
|
|
59
|
Long-term results of continuous treatment with recombinant interferon-alpha in patients with metastatic carcinoid tumors--an antiangiogenic effect?
|
Anticancer Drugs
|
1996
|
0.75
|
|
60
|
Effects and systemic uptake of the new mitomycin C analogue KW-2149 in beagle dogs after intravesical administration.
|
Urol Res
|
1995
|
0.75
|
|
61
|
Radiotherapy and chemotherapy in testis tumors.
|
J Belge Radiol
|
1993
|
0.75
|
|
62
|
Magnetic resonance imaging of primary malignant bone tumors.
|
Radiographics
|
1985
|
0.75
|
|
63
|
Control of anticoagulation in rats.
|
Experientia
|
1974
|
0.75
|
|
64
|
KW-2149-induced pulmonary toxicity is not prevented by corticosteroids: a phase I and pharmacokinetic study.
|
Anticancer Drugs
|
1999
|
0.75
|
|
65
|
[Interactions of carboplatin, cisplatin, and ionizing radiation on a human cell line of ovarian cancer].
|
Cancer Radiother
|
1999
|
0.75
|
|
66
|
The determination of cyclophosphamide and its metabolites in blood plasma as stable trifluoroacetyl derivatives by electron capture chemical ionization gas chromatography/mass spectrometry.
|
Biol Mass Spectrom
|
1994
|
0.75
|
|
67
|
Phase II trial of methylene dimethane sulphonate (MDMS) in advanced soft tissue sarcomas of the adult. A study of the EORTC Soft Tissue and Bone Sarcoma Group.
|
Eur J Cancer Clin Oncol
|
1989
|
0.75
|
|
68
|
Late relapse of a non-seminomatous germ cell tumour from residual mature teratoma.
|
Acta Clin Belg
|
1998
|
0.75
|
|
69
|
Diagnosis and treatment of soft tissue sarcomas in adults.
|
Curr Opin Oncol
|
1994
|
0.75
|
|
70
|
The influence of hypoxia on the cytotoxicity of concomitant KW-2149 and ionizing irradiation in Chinese hamster fibroblasts.
|
Anticancer Drugs
|
1996
|
0.75
|
|
71
|
Drug resistance in rat colon cancer cell lines is associated with minor changes in susceptibility to cytotoxic cells.
|
Cancer Immunol Immunother
|
1993
|
0.75
|
|
72
|
The management of ovarian cancer.
|
Ann Oncol
|
1993
|
0.75
|
|
73
|
Scintigraphic peritoneography in advanced ovarian malignancies: its value for chemotherapeutic distribution studies.
|
Clin Radiol
|
1984
|
0.75
|
|
74
|
[In vitro effects of piracetam on the radiosensitivity of hypoxic cells (adaptation of MTT assay to hypoxic conditions)].
|
Bull Cancer
|
1995
|
0.75
|
|
75
|
Comparison of daunorubicin and Fluo-3 for detection of multidrug resistance in human tumor cells.
|
Cancer Detect Prev
|
1997
|
0.75
|
|
76
|
Deep cerebral invasion by basal cell carcinoma of the scalp.
|
Neuroradiology
|
1996
|
0.75
|
|
77
|
Objective response criteria in phase II and phase III studies.
|
Prog Clin Biol Res
|
1988
|
0.75
|
|
78
|
Bioanalysis of suramin in human plasma by ion-pair high-performance liquid chromatography.
|
J Chromatogr
|
1990
|
0.75
|
|
79
|
Predictive testing in cancer chemotherapy. I. In vivo.
|
Pharm Weekbl Sci
|
1985
|
0.75
|
|
80
|
Cryptorchidism and extragonadal germ cell tumor.
|
Urol Int
|
1995
|
0.75
|